Want to learn more?  Please contact Keith Edwards, President & CEO.


N2 Biomedical prides itself on its highly specialized and experienced engineering team who work closely with our customers to commercialize innovative surface treatments.

The pathway for commercializing an implantable device can be long, but N2 Biomedical’s 30 years of experience, spotless track record and process-specific Master File submissions available for reference at FDA help to de-risk development. N2 Biomedical engineers leverage that foundation and continue to innovate finding solutions that:

  • Fight infection
  • Prevent nickel release
  • Improve biocompatibility

We value working closely with our customers on co-development projects to address important clinical challenges.